Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Shares outstanding
- 29,463,330
- Total 13F shares
- 28,529,838
- Share change
- +3,575,499
- Total reported value
- $5,239,051,095
- Put/Call ratio
- 64%
- Price per share
- $183.64
- Number of holders
- 245
- Value change
- +$658,436,118
- Number of buys
- 149
- Number of sells
- 109
Quarterly Holders Quick Answers
What is CUSIP 501147102?
CUSIP 501147102 identifies KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 501147102:
Top shareholders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
14%
|
4,243,892
|
$755,115,704 | — | 31 Mar 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8.7%
|
2,555,555
|
$454,709,901 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.3%
|
2,432,779
|
$432,864,367 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.1%
|
1,805,379
|
$321,231,085 | — | 31 Mar 2024 | |
| Redmile Group, LLC |
13F
|
Company |
5.1%
|
1,508,250
|
$268,362,923 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
3.4%
|
988,460
|
$175,876,688 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
944,547
|
$168,063,248 | — | 31 Mar 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
2.3%
|
670,735
|
$119,343,880 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.2%
|
658,618
|
$117,189,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
572,915
|
$101,938,767 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
525,745
|
$93,560,317 | — | 31 Mar 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.7%
|
495,586
|
$88,179,617 | — | 31 Mar 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
1.7%
|
492,232
|
$87,583,000 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.5%
|
434,574
|
$77,323,752 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
330,442
|
$58,793,056 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1.1%
|
321,946
|
$57,283,852 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.93%
|
275,455
|
$49,011,708 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.74%
|
218,829
|
$38,936,245 | — | 31 Mar 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.74%
|
217,747
|
$38,743,724 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
205,078
|
$36,489,528 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.64%
|
188,903
|
$33,611,510 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
0.6%
|
177,089
|
$31,509,446 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.59%
|
175,126
|
$31,160,169 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.58%
|
169,934
|
$30,236,357 | — | 31 Mar 2024 | |
| Allspring Global Investments Holdings, LLC |
13F
|
Company |
0.54%
|
158,425
|
$28,188,596 | — | 31 Mar 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.49%
|
142,960
|
$25,436,873 | — | 31 Mar 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
136,485
|
$24,284,776 | — | 31 Mar 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.46%
|
135,809
|
$24,164,000 | — | 31 Mar 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.46%
|
134,820
|
$23,988,523 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.45%
|
131,465
|
$23,391,568 | — | 31 Mar 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.44%
|
130,850
|
$23,282,140 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.42%
|
124,203
|
$22,099,440 | — | 31 Mar 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.37%
|
110,199
|
$19,607,708 | — | 31 Mar 2024 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.36%
|
105,200
|
$18,718,000 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.35%
|
103,969
|
$18,499,204 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.34%
|
101,557
|
$18,070,037 | — | 31 Mar 2024 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
0.33%
|
97,161
|
$17,288,000 | — | 31 Mar 2024 | |
| Capital World Investors |
13F
|
Company |
0.33%
|
97,147
|
$17,285,366 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
0.33%
|
95,858
|
$17,056,014 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.32%
|
93,745
|
$16,680,048 | — | 31 Mar 2024 | |
| S Squared Technology, LLC |
13F
|
Company |
0.31%
|
90,215
|
$16,051,955 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
89,839
|
$15,985,115 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.3%
|
89,628
|
$15,947,510 | — | 31 Mar 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.29%
|
84,100
|
$14,963,913 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.28%
|
82,027
|
$14,595,064 | — | 31 Mar 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.27%
|
80,000
|
$14,234,400 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.26%
|
75,844
|
$13,494,922 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
69,162
|
$12,305,995 | — | 31 Mar 2024 | |
| Decheng Capital LLC |
13F
|
Company |
0.22%
|
65,772
|
$11,702,812 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
0.21%
|
61,800
|
$10,996,074 | — | 31 Mar 2024 |
Institutional Holders of Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) as of Q2 2024
As of 30 Jun 2024,
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS) was held by
245 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,529,838 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Redmile Group, LLC, Frazier Life Sciences Management, L.P., Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, and DIMENSIONAL FUND ADVISORS LP.
This page lists
245
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
233
Q2 2024 holders
245
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.